These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 14715694

  • 1. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors.
    Gräler MH, Goetzl EJ.
    FASEB J; 2004 Mar; 18(3):551-3. PubMed ID: 14715694
    [Abstract] [Full Text] [Related]

  • 2. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.
    Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, Allende ML, Proia RL, Cyster JG.
    Nature; 2004 Jan 22; 427(6972):355-60. PubMed ID: 14737169
    [Abstract] [Full Text] [Related]

  • 3. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
    Miron VE, Jung CG, Kim HJ, Kennedy TE, Soliven B, Antel JP.
    Ann Neurol; 2008 Jan 22; 63(1):61-71. PubMed ID: 17918267
    [Abstract] [Full Text] [Related]

  • 4. Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes.
    Forrest M, Sun SY, Hajdu R, Bergstrom J, Card D, Doherty G, Hale J, Keohane C, Meyers C, Milligan J, Mills S, Nomura N, Rosen H, Rosenbach M, Shei GJ, Singer II, Tian M, West S, White V, Xie J, Proia RL, Mandala S.
    J Pharmacol Exp Ther; 2004 May 22; 309(2):758-68. PubMed ID: 14747617
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
    Chiba K, Matsuyuki H, Maeda Y, Sugahara K.
    Cell Mol Immunol; 2006 Feb 22; 3(1):11-9. PubMed ID: 16549044
    [Abstract] [Full Text] [Related]

  • 7. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.
    Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J, Thornton R, Shei GJ, Card D, Keohane C, Rosenbach M, Hale J, Lynch CL, Rupprecht K, Parsons W, Rosen H.
    Science; 2002 Apr 12; 296(5566):346-9. PubMed ID: 11923495
    [Abstract] [Full Text] [Related]

  • 8. FTY720 inhibits S1P-mediated endothelial healing: relationship to S1P1-receptor surface expression.
    Krump-Konvalinkova V, Chwalla I, Siess W.
    Biochem Biophys Res Commun; 2008 Jun 13; 370(4):603-8. PubMed ID: 18402775
    [Abstract] [Full Text] [Related]

  • 9. Cis-4-methylsphingosine is a sphingosine-1-phosphate receptor modulator.
    Ter Braak M, Claas RF, Hegen B, Labocha S, Ferreirós N, Pfeilschifter J, Huwiler A, van Echten-Deckert G, Meyer Zu Heringdorf D.
    Biochem Pharmacol; 2011 Mar 01; 81(5):617-25. PubMed ID: 21163254
    [Abstract] [Full Text] [Related]

  • 10. Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis.
    Lee CW, Choi JW, Chun J.
    Arch Pharm Res; 2010 Oct 01; 33(10):1567-74. PubMed ID: 21052934
    [Abstract] [Full Text] [Related]

  • 11. Topical treatment targeting sphingosine-1-phosphate and sphingosine lyase abrogates experimental allergic rhinitis in a murine model.
    Kleinjan A, van Nimwegen M, Leman K, Hoogsteden HC, Lambrecht BN.
    Allergy; 2013 Feb 01; 68(2):204-12. PubMed ID: 23253209
    [Abstract] [Full Text] [Related]

  • 12. Attenuation of cell motility observed with high doses of sphingosine 1-phosphate or phosphorylated FTY720 involves RGS2 through its interactions with the receptor S1P.
    Kohno T, Igarashi Y.
    Genes Cells; 2008 Jul 01; 13(7):747-57. PubMed ID: 18513330
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
    Walter DH, Rochwalsky U, Reinhold J, Seeger F, Aicher A, Urbich C, Spyridopoulos I, Chun J, Brinkmann V, Keul P, Levkau B, Zeiher AM, Dimmeler S, Haendeler J.
    Arterioscler Thromb Vasc Biol; 2007 Feb 01; 27(2):275-82. PubMed ID: 17158356
    [Abstract] [Full Text] [Related]

  • 15. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
    Maeda Y, Seki N, Sato N, Sugahara K, Chiba K.
    Int Immunol; 2010 Jun 01; 22(6):515-25. PubMed ID: 20497959
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Biochemical regulation of breast cancer cell expression of S1P2 (Edg-5) and S1P3 (Edg-3) G protein-coupled receptors for sphingosine 1-phosphate.
    Dolezalova H, Shankar G, Huang MC, Bikle DD, Goetzl EJ.
    J Cell Biochem; 2003 Mar 01; 88(4):732-43. PubMed ID: 12577307
    [Abstract] [Full Text] [Related]

  • 19. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Nofer JR, Bot M, Brodde M, Taylor PJ, Salm P, Brinkmann V, van Berkel T, Assmann G, Biessen EA.
    Circulation; 2007 Jan 30; 115(4):501-8. PubMed ID: 17242282
    [Abstract] [Full Text] [Related]

  • 20. Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy.
    Sensken SC, Bode C, Gräler MH.
    J Pharmacol Exp Ther; 2009 Mar 30; 328(3):963-9. PubMed ID: 19074680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.